LSV Asset Management’s Community Health Systems CYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-118,300
Closed -$908K 985
2017
Q3
$908K Hold
118,300
﹤0.01% 809
2017
Q2
$1.18M Sell
118,300
-191,100
-62% -$1.75M ﹤0.01% 787
2017
Q1
$2.74M Sell
309,400
-34,400
-10% -$268K 0.01% 663
2016
Q4
$1.92M Sell
343,800
-572,000
-62% -$3.97M ﹤0.01% 715
2016
Q3
$10.6M Sell
915,800
-17,000
-2% -$196K 0.02% 425
2016
Q2
$11.2M Sell
932,800
-241,021
-21% -$3.53M 0.02% 400
2016
Q1
$18M Buy
1,173,821
+650,496
+124% +$9.93M 0.04% 308
2015
Q4
$11.5M Buy
523,325
+486,299
+1,313% +$12.6M 0.02% 364
2015
Q3
$1.31M Buy
+37,026
New +$1.7M ﹤0.01% 690
2014
Q3
Sell
-255,552
Closed -$9.58M 906
2014
Q2
$9.58M Sell
255,552
-1,729,033
-87% -$57.5M 0.02% 369
2014
Q1
$64.2M Sell
1,984,585
-148,120
-7% -$4.89M 0.15% 140
2013
Q4
$69.2M Sell
2,132,705
-56,991
-3% -$1.96M 0.16% 139
2013
Q3
$75.1M Sell
2,189,696
-253,439
-10% -$8.99M 0.19% 124
2013
Q2
$94.7M Buy
+2,443,135
New +$92M 0.25% 110

Other funds holding CYH

LSV Asset Management's CYH Position: Q4 2017 in Review

LSV Asset Management sold out of Community Health Systems (CYH) in Q4 2017, closing a stake of 118,300 shares — an estimated $908K sold.

LSV Asset Management first reported a position in CYH in Q2 2013 and held it in 14 quarters. The position peaked at $94.7M in Q2 2013. 192 funds tracked by Wall St. Rank hold CYH as of Q4 2017.

  • LSV Asset Management reported no remaining Community Health Systems position as of Q4 2017 after selling out during the quarter.
  • LSV Asset Management sold 118,300 Community Health Systems shares in Q4 2017, an estimated $908K.
  • LSV Asset Management first reported a position in Community Health Systems in Q2 2013 and held it in 14 quarters.
  • LSV Asset Management's Community Health Systems position peaked at $94.7M in Q2 2013.
  • 192 funds tracked by Wall St. Rank held Community Health Systems as of Q4 2017.

Based on LSV Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.